Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
vandetanib
.
Show all posts
Showing posts with label
vandetanib
.
Show all posts
Thursday, February 16, 2017
Novel combination therapy shows strong response in phase 1 trial
›
In continuation of my update on Sorafenib , Premetrexed , Vandetanib "Though phase 1 studies are designed to evaluate the safety ...
Monday, July 30, 2012
Drug Combo Tackling Solid Tumors
›
Cancer Research UK's Drug Development Office has opened the first trial of a new drug combination in patients with advanced solid tu...
Saturday, April 9, 2011
AstraZeneca receives FDA approval for vandetanib to treat medullary thyroid cancer
›
In continuation of my update on Vandetanib ,,,,, AstraZeneca receives FDA approval for vandetanib to treat medullary thyroid cancer
Friday, October 22, 2010
FDA and EMA accept regulatory submissions of vandetanib for advanced medullary thyroid cancer
›
We know that , Vandetanib (proposed trade name Zactima ), also known as ZD6474 , is an antagonist of the vascular endothelial growth...
›
Home
View web version